PrecisionLife announces strategic CNS drug development collaboration with Nanopharmaceutics
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
Subscribe To Our Newsletter & Stay Updated